These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35884993)

  • 1. Differential Neuropathology, Genetics, and Transcriptomics in Two Kindred Cases with Alzheimer's Disease and Lewy Body Dementia.
    Palmieri I; Poloni TE; Medici V; Zucca S; Davin A; Pansarasa O; Ceroni M; Tronconi L; Guaita A; Gagliardi S; Cereda C
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On gaps of clinical diagnosis of dementia subtypes: A study of Alzheimer's disease and Lewy body disease.
    Wei H; Masurkar AV; Razavian N
    Front Aging Neurosci; 2023; 15():1149036. PubMed ID: 37025965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation.
    Rajkumar AP; Bidkhori G; Shoaie S; Clarke E; Morrin H; Hye A; Williams G; Ballard C; Francis P; Aarsland D
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):75-86. PubMed ID: 31327631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Lewy body dementia and the impact of vascular components.
    Londos E; Passant U; Brun A; Gustafson L
    Int J Geriatr Psychiatry; 2000 Jan; 15(1):40-9. PubMed ID: 10637403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
    Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease.
    Barba L; Abu-Rumeileh S; Barthel H; Massa F; Foschi M; Bellomo G; Gaetani L; Thal DR; Parnetti L; Otto M
    Brain; 2024 Jul; ():. PubMed ID: 38991041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
    Malek-Ahmadi M; Beach TG; Zamrini E; Adler CH; Sabbagh MN; Shill HA; Jacobson SA; Belden CM; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Caviness JN; Driver-Dunckley E; Mehta SH; Shprecher DR; Spann BM; Tariot P; Davis KJ; Long KE; Nicholson LR; Intorcia A; Glass MJ; Walker JE; Callan M; Curry J; Cutler B; Oliver J; Arce R; Walker DG; Lue LF; Serrano GE; Sue LI; Chen K; Reiman EM
    PLoS One; 2019; 14(6):e0217566. PubMed ID: 31237877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
    Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
    BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia.
    Kawakatsu S; Kobayashi R; Hayashi H; Morioka D; Utsunomiya A; Kabasawa T; Ohe R; Otani K
    Neuropathology; 2021 Dec; 41(6):427-449. PubMed ID: 34816507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
    Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia.
    Burton EJ; Mukaetova-Ladinska EB; Perry RH; Jaros E; Barber R; O'Brien JT
    Neurobiol Aging; 2012 Jul; 33(7):1228-36. PubMed ID: 21353336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia.
    Burton EJ; Mukaetova-Ladinska EB; Perry RH; Jaros E; Barber R; O'Brien JT
    Int J Geriatr Psychiatry; 2012 Dec; 27(12):1267-74. PubMed ID: 22383167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
    Jellinger KA
    J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
    J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.